AAICare™ - TB
Combining artificial intelligence with targeted analysis of a whole genome sequence AAICare™ - TB generates comprehensive drug susceptibility reports for Drug-Resistant Tuberculosis (DR-TB)
Explore AAICare™ - TB
8
countries bear two-thirds of the global TB burden
2.64
million people are affected in India alone
41
%of MR-TB cases are unsuccessfully treated globally
According to WHO's Global TB Report 2021
AAICare™ - TB predicts resistance mutations, heteroresistance and lineage for 19 drugs and generates a phylogenetic tree to understand evolution of the pathogens.
AAICare™ - TB produces findings in hours rather than weeks using a reliable detection pipeline and tools including batch processing, an intuitive interface, and sequencing machine interoperability.
AAICare™ - TB is equipped to identify all pathogens present in the patient sample including Mycobacterium and Mycobacteria other than Tuberculosis.
Sign up here for latest updates from us